Weller M - Search Results

1

Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.

Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, Brown PD, Camidge DR, Chiang VL, Davies MA, Hu LS, Huang RY, Kaufmann T, Kumthekar P, Lam K, Lee EQ, Lin NU, Mehta M, Parsons M, Reardon DA, Sheehan J, Soffietti R, Tawbi H, Weller M, Wen PY. Aizer AA, et al. Among authors: weller m. Neuro Oncol. 2022 Oct 3;24(10):1613-1646. doi: 10.1093/neuonc/noac118. Neuro Oncol. 2022. PMID: 35762249 Free PMC article. Review.

2

New aspects of immunotherapy of leptomeningeal metastasis.

Herrlinger U, Weller M, Schabet M. Herrlinger U, et al. Among authors: weller m. J Neurooncol. 1998 Jun-Jul;38(2-3):233-9. doi: 10.1023/a:1005948722912. J Neurooncol. 1998. PMID: 9696377 Review.

3

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity.

Hegi ME, Liu L, Herman JG, Stupp R, Wick W, Weller M, Mehta MP, Gilbert MR. Hegi ME, et al. Among authors: weller m. J Clin Oncol. 2008 Sep 1;26(25):4189-99. doi: 10.1200/JCO.2007.11.5964. J Clin Oncol. 2008. PMID: 18757334 Free article. Review.

4

Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro.

Maurer GD, Tritschler I, Adams B, Tabatabai G, Wick W, Stupp R, Weller M. Maurer GD, et al. Among authors: weller m. Neuro Oncol. 2009 Dec;11(6):747-56. doi: 10.1215/15228517-2009-012. Neuro Oncol. 2009. PMID: 19221171 Free PMC article.

5

Targeting integrins in malignant glioma.

Tabatabai G, Weller M, Nabors B, Picard M, Reardon D, Mikkelsen T, Ruegg C, Stupp R. Tabatabai G, et al. Among authors: weller m. Target Oncol. 2010 Sep;5(3):175-81. doi: 10.1007/s11523-010-0156-3. Epub 2010 Sep 4. Target Oncol. 2010. PMID: 20820929 Review.

6

Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies.

Reardon DA, Neyns B, Weller M, Tonn JC, Nabors LB, Stupp R. Reardon DA, et al. Among authors: weller m. Future Oncol. 2011 Mar;7(3):339-54. doi: 10.2217/fon.11.8. Future Oncol. 2011. PMID: 21417900 Free article.

7

Phase 2 trial design in neuro-oncology revisited: a report from the RANO group.

Galanis E, Wu W, Cloughesy T, Lamborn K, Mann B, Wen PY, Reardon DA, Wick W, Macdonald D, Armstrong TS, Weller M, Vogelbaum M, Colman H, Sargent DJ, van den Bent MJ, Gilbert M, Chang S. Galanis E, et al. Among authors: weller m. Lancet Oncol. 2012 May;13(5):e196-204. doi: 10.1016/S1470-2045(11)70406-5. Lancet Oncol. 2012. PMID: 22554547 Review.

8

Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.

Weller M, Stupp R, Hegi ME, van den Bent M, Tonn JC, Sanson M, Wick W, Reifenberger G. Weller M, et al. Neuro Oncol. 2012 Sep;14 Suppl 4(Suppl 4):iv100-8. doi: 10.1093/neuonc/nos206. Neuro Oncol. 2012. PMID: 23095825 Free PMC article. Review.

9

Standards of care for treatment of recurrent glioblastoma--are we there yet?

Weller M, Cloughesy T, Perry JR, Wick W. Weller M, et al. Neuro Oncol. 2013 Jan;15(1):4-27. doi: 10.1093/neuonc/nos273. Epub 2012 Nov 7. Neuro Oncol. 2013. PMID: 23136223 Free PMC article. Review.

10

Invasion patterns in brain metastases of solid cancers.

Berghoff AS, Rajky O, Winkler F, Bartsch R, Furtner J, Hainfellner JA, Goodman SL, Weller M, Schittenhelm J, Preusser M. Berghoff AS, et al. Among authors: weller m. Neuro Oncol. 2013 Dec;15(12):1664-72. doi: 10.1093/neuonc/not112. Epub 2013 Sep 30. Neuro Oncol. 2013. PMID: 24084410 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,664 results

Search Page